Jamie L. Habib

June 11, 2012

In a highly critical re-analysis of the Women’s Health Initiative (WHI) study of 2002, the results of which prompted safety fears about hormone replacement therapy (HRT) significantly increasing the risk of breast cancer, it was concluded that the weight of evidence supports benefits over risks for use of HRT in women with severe symptoms of menopause or other conditions.

June 08, 2012

In anovulatory women with polycystic ovary syndrome (PCOS), one-time use of progestin to induce withdrawal bleeding before ovulation induction may decrease the odds of conception and live birth, according to a new study conducted by researchers for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIHCD) Cooperative Reproductive Medicine Network (RMN).

June 06, 2012

Whether a woman is overweight or obese before and during pregnancy, and not glucose levels, is the most reliable predictor of a woman’s risk of giving birth to a large-for-gestational-age infant, according to a new study conducted in Canada.

June 04, 2012

The use of the anti-HIV drug tenofovir during pregnancy does not affect birth weight or birth length, according to new research conducted as part of the Pediatric HIV/AIDS Cohort Study. The impetus for this study was that previous research in laboratory animals showed that exposure to tenofovir in the womb was associated with smaller birth size compared with animals not exposed to the drug.

June 01, 2012

Dietary and lifestyle interventions in pregnancy can reduce maternal gestational weight gain and improve outcomes for both mother and baby, according to a new study. In Europe and the United States, 20% to 40% of women gain more than the recommended amount of weight during pregnancy.

May 30, 2012

Elective induction of labor between 37 and 41 weeks of gestation can lower perinatal mortality rates in developed countries without increasing the risk of cesarean deliveries, according to a new study conducted in Scotland.